New multi-centre study in Spain shows very strong interim results for Prostatype®
Prostatype Genomics is currently conducting a study of 160 patients together with seven leading Spanish hospitals and the Spanish National Association of Urology. The initial results are very strong and show that approximately 60% of patients would have been reclassified if Prostatype® had been used for prognosis and treatment decisions after diagnosis.In a new retrospective multicentre study with Prostatype® in Spain including 160 patients from a total of seven hospitals, coordinated by the Spanish National Association of Urology, an interim analysis has been performed after three